Ilona Jonik

Ilona Jonik

Auto-generated profile, based on publicly available information

Ilona Jonik

Department of Biomedical and Analytical Chemistry, Institute of Biological Sciences, Faculty of Medicine, The John Paul II Catholic University of Lublin, Konstantynów 1J St., 20-708 Lublin, Poland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in Food Control
Verified
Journal Article
Open access
Ilona SadokIlona Sadok
Ilona Sadok
KRKamila Rachwał
Kamila Rachwał
IJIlona Jonik
Ilona Jonik
GŻGrzegorz Żukociński
Grzegorz Żukociński
OKOliwia Kwiatkowska
Oliwia Kwiatkowska

6 February 2021 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
Ilona SadokIlona Sadok
Ilona Sadok
KRKamila Rachwał
Kamila Rachwał
IJIlona Jonik
Ilona Jonik
Magdalena StaniszewskaMagdalena Staniszewska
Magdalena Staniszewska
The kynurenine pathway is the major tryptophan degradation routes generating bioactive compounds important in physiology and diseases. Depending on cell type it is initiated enzymatically by tryptophan-2,3-dioxygenase (TDO) or indoleamine-2,3-dioxygenase 1 and 2 (IDO1 and IDO2) to yield N-formylkynurenine as the precursor of further metabolites. Herein, we describe an accurate high-pressure liquid chromatography coupled with a diode array detector (HPLC-DAD) method to serve for IDO1 activity determination in human cancer cells cultured in vitro. Enzymatic activity was expressed as the rate of ʟ-kynurenine generation by 1 mg of proteins obtained from cancer cells. Our approach shows the limit of detection and limit of quantification at 12.9 and 43.0 nM Kyn, respectively. Applicability of this method was demonstrated in different cells (ovarian and breast cancer)exposed to various conditions and has successfully passed the validation process. This approach presents a useful model to study the role of kynurenine pathway in cancer biology.

21 July 2026 in Food Chemistry
Verified
Journal Article
Open access
Ilona SadokIlona Sadok
Ilona Sadok
IJIlona Jonik
Ilona Jonik
KRKamila Rachwał
Kamila Rachwał
Paulina IwaniakPaulina Iwaniak
Paulina Iwaniak
KWKatarzyna Wicha-Komsta
Katarzyna Wicha-Komsta
Kombucha is gaining global popularity for its health benefits. This study explored the use of chestnut honey, a rich source of kynurenic acid (KYNA), to produce kombucha enriched with this metabolite. Five variants were prepared using different green/black tea blends and carbon sources: white sugar or acacia honey (controls) versus chestnut honey. Samples were analyzed for tryptophan metabolites, physicochemical properties, and microbial diversity. Komagataeibacter and Enterobacter were predominant bacterial genera in SCOBY. Candida and Aspergillus were predominated in the single sample analyzed for fungi. During fermentation, tryptophan decreased, while kynurenine increased. KYNA levels remained largely stable during fermentation and were mainly influenced by the fermentation substrate. No melatonin pathway derivatives were detected. On day 7, chestnut honey yielded kombucha with 381.680-739.915 μmol/L KYNA and elevated myricetin. Overall, chestnut honey-based kombucha represents a system in which substrate composition appears to be the main factor influencing KYNA levels in the final beverage.